Stereotactic Body Radiotherapy for Hepatocellular Carcinoma: A Brief Overview.
Matsuo Y.
Curr Oncol. 2023 Feb 18;30(2):2493-2500. doi: 10.3390/curroncol30020190.
PMID:36826151
Stereotactic body radiotherapy for Ultra-Central lung Tumors: A systematic review and Meta-Analysis and International Stereotactic Radiosurgery Society practice guidelines.
Yan M, Louie AV, Kotecha R, Ashfaq Ahmed M, Zhang Z, Guckenberger M, Kim MS, Lo SS, Scorsetti M, Tree AC, Sahgal A, Slotman BJ.
Lung Cancer. 2023 Aug;182:107281. doi: 10.1016/j.lungcan.2023.107281. Epub 2023 Jun 21.
PMID:37393758
Stereotactic Body Radiotherapy for Liver Metastases.
Semin Oncol. 2014 Dec;41(6):776-89. doi: 10.1053/j.seminoncol.2014.09.022. Epub 2014 Oct 7.
PMID:25499636
Dose prescription for stereotactic body radiotherapy: general and organ-specific consensus statement from the DEGRO/DGMP Working Group Stereotactic Radiotherapy and Radiosurgery.
Brunner TB, Boda-Heggemann J, Bürgy D, Corradini S, Dieckmann UK, Gawish A, Gerum S, Gkika E, Grohmann M, Hörner-Rieber J, Kirste S, Klement RJ, Moustakis C, Nestle U, Niyazi M, Rühle A, Lang ST, Winkler P, Zurl B, Wittig-Sauerwein A, Blanck O.
Stereotactic body radiotherapy as metastasis-directed therapy in oligometastatic prostate cancer: a systematic review and meta-analysis of randomized controlled trials.
Persson AE, Hallqvist A, Bjørn Larsen L, Rasmussen M, Scherman J, Nilsson P, Tønnesen H, Gunnlaugsson A.
Radiat Oncol. 2024 Dec 17;19(1):173. doi: 10.1186/s13014-024-02559-7.
PMID:39690404
Stereotactic body radiotherapy for spinal oligometastases: a review on patient selection and the optimal methodology.